Enekinragene Inzadenovec (PCRX-201) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11 (month) in 1mo
ESTIMATED |
READOUT
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful O
Phase 2 · Osteoarthritis (OA) of the Knee |
PCRX Pacira BioSciences, Inc. | Enekinragene Inzadenovec (PCRX-201) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|